Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,957 total articles
Daktronics, a leading US-based designer and manufacturer of dynamic video displays and control systems, will ring the Nasdaq Closing Bell on April 8, 2026, marking a milestone event shortly after announcing its fiscal third quarter results and ahead of its Investor Day. The event symbolizes Daktronics' focus on accelerating profitable growth and ce…
First Merchants Corporation, a financial holding company based in Muncie, Indiana, will report its first quarter 2026 financial results on April 22, 2026. The company will host a conference call and webcast on April 23, 2026, to discuss the results. The stock is traded on NASDAQ under the ticker symbol FRME.
Celldex Therapeutics, a clinical-stage biotechnology company, announced the pricing of an underwritten public offering of 10,345,000 shares at $29.00 per share, expecting gross proceeds of approximately $300 million. The offering aims to fund its commercial readiness and potential launch of barzolvolimab for chronic spontaneous urticaria, continue …
Telesat Corporation announced a significant multi-year agreement with Northwestel to provide advanced Lightspeed Low Earth Orbit (LEO) satellite services. This deal aims to deliver high-speed, low-latency sovereign broadband to remote communities in Northern Canada, supporting economic growth, education, healthcare, and broader digital participatio…
Immunovant announced that its Phase 3 clinical trials for batoclimab in treating thyroid eye disease (TED) failed to meet their primary efficacy endpoint. While safety profiles were consistent with previous results and no new risks identified, the drug did not achieve the targeted proptosis improvement at 24 weeks. The company highlighted promising…
Futu Holdings Limited, a Nasdaq-listed online brokerage and wealth management platform, declared a cash dividend of $0.325 per ordinary share (equivalent to $2.6 per American Depositary Share), totaling approximately $365 million, payable to shareholders as of April 16, 2026, with payment expected around April 29, 2026.
Priovant Therapeutics announced the initiation of a seamless Phase 2b/3 clinical trial for brepocitinib in treating Lichen Planopilaris (LPP), a severe inflammatory scalp disorder with no FDA-approved treatments. This marks the fourth indication in brepocitinib's late-stage development alongside dermatomyositis, non-infectious uveitis, and cutaneou…
Roivant Sciences announced the expansion of its brepocitinib development program to include a new seamless Phase 2b/3 clinical trial for the inflammatory scalp disorder lichen planopilaris (LPP), which currently has no FDA-approved treatments. Concurrently, Roivant reported topline results from Immunovant's Phase 3 studies of batoclimab in thyroid …
Acuity Inc. delivered a robust second-quarter fiscal 2026 performance marked by 5% net sales growth to $1.1 billion, 21% increase in operating profit to $133 million, and a 26% rise in diluted EPS to $3.09. The company's two business segments had mixed results: Acuity Brands Lighting sales slightly declined by 2.8%, while Acuity Intelligent Spaces …
Global Net Lease, Inc. announced that board members Sue Perrotty and Governor Edward Rendell will retire following the 2026 Annual Meeting of Stockholders, reducing the board size to eight members. The company acknowledges their contributions, particularly during the 2023 merger and internalization process.
Burning Rock Biotech Limited announced that founder, chairman, and CEO Yusheng Han purchased 31,487 American Depositary Shares (ADSs) for $546,603.90 on the open market, adding to prior purchases this year. These transactions signal strong insider confidence in the company's precision oncology business, which focuses on next generation sequencing (…
Transocean Ltd. announced $1 billion in new and extended offshore drilling contracts spanning Norway and Brazil, along with the early retirement of $358 million in senior secured notes. These developments strengthen the company's backlog, reduce interest expenses, and support its deleveraging strategy.
Scorpio Tankers Inc. has entered into a strategic collaboration with AMPERA, Inc. to jointly develop and commercialize advanced micronuclear power solutions aimed at powering maritime vessels, offshore, and port infrastructure with zero carbon emissions. The collaboration focuses on deploying ultra-safe micro nuclear reactors, including floating nu…
Akebia Therapeutics announced inducement grants of stock options to 13 newly hired employees as part of their onboarding process, with options totaling 679,900 shares granted at an exercise price equivalent to the closing stock price on the grant date. These options will vest over four years and have a 10-year term.
Freight Technologies announced significant progress in transforming into a software-first, AI-native logistics technology company, focusing on scaling its AI-powered platforms like Fleet Rocket, Zayren, and Fr8Radar. The company is exploring strategic alternatives for its traditional brokerage operations to concentrate resources on its AI software …
PMGC Holdings Inc. announced the formation of NorthStrive Defense Tech LLC, a wholly owned subsidiary targeting the high-growth defense technology sector, specifically drone and autonomous systems. This strategic move leverages PMGC's existing aerospace and defense subsidiaries to accelerate commercialization of advanced defense technologies throug…
AirSculpt Technologies, a US-based provider of body contouring procedures, reported its fourth quarter and full year 2025 financial results. The company saw a decline in case volume and revenue compared to 2024 but delivered improved adjusted EBITDA and reduced net losses in Q4. The company implemented new strategies and procedures during 2025, lea…
Encore Capital Group, a specialty finance company focused on consumer debt recovery, will release its Q1 2026 financial results on May 6, 2026, followed by an investor conference call and webcast. The company engages in purchasing consumer receivables portfolios from banks and utility providers and emphasizes a consumer-first approach with its Cons…
Fate Therapeutics announced the issuance of restricted stock units (RSUs) totaling 7,260 shares to a newly hired non-executive employee as an inducement to join the company. The RSUs vest over four years and were approved by the Compensation Committee in compliance with Nasdaq Listing Rule 5635(c)(4).
Candel Therapeutics, a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies for cancer treatment, announced inducement stock option grants totaling 70,000 shares to five new employees. These grants are made under the company's 2025 Inducement Plan pursuant to Nasdaq Listing Rule 5635(c)(4). The awards…
Minerva Neurosciences, a clinical-stage biotech focused on CNS disorders, announced that Jim O'Connor will become Chief Business Officer, replacing departing President Geoff Race who will remain as consultant. The leadership change occurs as Minerva prepares to advance its key drug candidate, roluperidone, through a planned Phase 3 trial targeting …
Financial Institutions, Inc., parent company of Five Star Bank and Courier Capital, announced it will release its Q1 2026 financial results after market close on April 23, 2026. The company will host an earnings conference call and webcast on April 24, 2026, to discuss the results.
Grocery Outlet Holding Corp., a U.S.-based extreme value retailer, announced the appointment of Frances Allen and Felicia Thornton to its Board of Directors to enhance expertise aligned with strategic priorities. Both bring extensive experience in grocery and retail sectors, brand strategy, marketing, finance, and operations. These strategic additi…
Ethos Technologies Inc., a life insurance technology company focused on democratizing access to life insurance, announced it will release its Q1 2026 financial results on May 6, 2026, after U.S. market close. The company also plans a conference call and live webcast for investors to discuss the results.
Relay Therapeutics announced it will present initial clinical and preclinical data on its lead drug candidate, zovegalisib, a mutant-selective PI3Kα inhibitor, in PIK3CA-driven vascular anomalies at the ISSVA World Congress 2026. Zovegalisib is also in advanced development for HR+/HER2- metastatic breast cancer and aims to address a large patient p…
